Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility
Zhuoying Chen, Li Chen, Lichun Wu, Ke Zhang · 2026
Read Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility by Zhuoying Chen, Li Chen, Lichun Wu, Ke Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571286.txt.
Description
Zhuoying Chen, Li Chen, Lichun Wu, and Ke Zhang weigh blood tumor markers for telling two lung cancer types apart in a 2026 study. The types are lung adenocarcinoma and lung squamous cell carcinoma. Both sit in non-small cell lung cancer, but their care and course can split, so a cheap blood call has worth.
Records covered more than a thousand patients with a proven type. A panel of markers was read for each. Some marks ran high in the squamous type, and one ran high in the other. Two marks split the types best on their own. Cost and net gain for care were scored as well.
Catalog record
| CREATOR | Zhuoying Chen, Li Chen, Lichun Wu, Ke Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |